Cargando…
Availability of drugs for severe COVID-19 in sub-Saharan Africa
Autores principales: | Njonnou, Sylvain Raoul Simeni, Ouankou, Christian Ngongang, Lekpa, Fernando Kemta, Balti, Eric Vounsia, Choukem, Simeon Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875718/ https://www.ncbi.nlm.nih.gov/pubmed/33623573 http://dx.doi.org/10.11604/pamj.supp.2020.35.2.23698 |
Ejemplares similares
-
The challenge of COVID-19 case identification and ascertainment in sub-Saharan Africa: the case of Cameroon
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2020) -
The COVID-19 Prevalence among Children: Hypotheses for Low Infection Rate and Few Severe Forms among This Age Group in Sub-Saharan Africa
por: Simeni Njonnou, Sylvain Raoul, et al.
Publicado: (2021) -
Use of WhatsApp®, for distance teaching during COVID-19 pandemic: Experience and perception from a sub-Saharan African setting
por: Enyama, Dominique, et al.
Publicado: (2021) -
Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021) -
Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong
por: Lekpa, Fernando Kemta, et al.
Publicado: (2021)